Skip to main content
OverweightWeight lossPeptides and GLP-1DrugPhase 3

What this study is

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as oral tablets once a day. Participants will either get zenagamtide (the treatment being tested) or Placebo (treatment that has no active medicine in it). Which treatment participants get is decided by chance.

What's being tested

  • zenagamtide

    Intervention · DRUG

    zenagamtide will be taken orally.

  • Placebo

    Intervention · DRUG

    Placebo matched to zenagamtide will be taken orally.

Study details

Official title
Efficacy and Safety of Once-daily Oral Zenagamtide in Participants With Obesity (AMAZE 9)
Sponsor
Novo Nordisk A/S
Conditions
Overweight · Obesity
Enrolling
950 people
Starts
2026-08-31
Est. completion
2028-08-22
Design
Quadruple-blind, randomized, parallel groups, Phase 3
Record
View on ClinicalTrials.gov ↗